ES453043A1 - Procedimiento para la obtencion de derivados del acido 13- tiaprostanico. - Google Patents

Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.

Info

Publication number
ES453043A1
ES453043A1 ES453043A ES453043A ES453043A1 ES 453043 A1 ES453043 A1 ES 453043A1 ES 453043 A ES453043 A ES 453043A ES 453043 A ES453043 A ES 453043A ES 453043 A1 ES453043 A1 ES 453043A1
Authority
ES
Spain
Prior art keywords
formula
compound
acid
agent
transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES453043A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES453043A1 publication Critical patent/ES453043A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
ES453043A 1975-11-07 1976-11-05 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico. Expired ES453043A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550004A DE2550004C2 (de) 1975-11-07 1975-11-07 Thiaprostaglandine sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ES453043A1 true ES453043A1 (es) 1977-12-16

Family

ID=5961171

Family Applications (2)

Application Number Title Priority Date Filing Date
ES453043A Expired ES453043A1 (es) 1975-11-07 1976-11-05 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.
ES463723A Expired ES463723A1 (es) 1975-11-07 1977-10-31 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES463723A Expired ES463723A1 (es) 1975-11-07 1977-10-31 Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.

Country Status (7)

Country Link
JP (1) JPS6032625B2 (es)
CA (1) CA1072549A (es)
CH (1) CH625211A5 (es)
DE (1) DE2550004C2 (es)
ES (2) ES453043A1 (es)
NL (1) NL7612320A (es)
SE (1) SE7612368L (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025325A1 (de) * 1980-07-04 1982-02-04 Merck Patent Gmbh, 6100 Darmstadt Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
JP2696933B2 (ja) * 1987-06-16 1998-01-14 日産化学工業株式会社 置換環状ケトン及び置換環状エノン並びにそれらの製造法
US5231208A (en) * 1987-06-16 1993-07-27 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5227505A (en) * 1987-06-16 1993-07-13 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US5254708A (en) * 1987-06-16 1993-10-19 Nissan Chemical Industries, Ltd. Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
WO1998039293A2 (en) * 1997-03-07 1998-09-11 Alcon Laboratories, Inc. 13-thia prostaglandins for use in glaucoma therapy

Also Published As

Publication number Publication date
ES463723A1 (es) 1978-06-16
JPS5259138A (en) 1977-05-16
SE7612368L (sv) 1977-05-08
NL7612320A (nl) 1977-05-10
CH625211A5 (en) 1981-09-15
DE2550004C2 (de) 1984-04-26
DE2550004A1 (de) 1977-05-18
CA1072549A (en) 1980-02-26
JPS6032625B2 (ja) 1985-07-29

Similar Documents

Publication Publication Date Title
ES456653A1 (es) Procedimiento para preparar acidos carboxilicos y sus deri- vados.
ES455588A1 (es) Un metodo de preparar un material fotosensible que incluye un compuesto de cumarina 3-sustituida.
ES394370A1 (es) Procedimiento para la preparacion de derivados de la inso-indolina.
ES453043A1 (es) Procedimiento para la obtencion de derivados del acido 13- tiaprostanico.
ES446534A1 (es) Procedimiento para la obtencion de nuevos derivados de acido13-tiaprostanico.
ES396134A1 (es) Procedimiento para la preparacion de derivados de 1,1,1- tricloroetano.
ES421067A1 (es) Procedimiento para la preparacion de nuevas 2-fenilamino- imidazolinas sustituidas.
ES463783A1 (es) Un procedimiento para la preparacion de cis-4a-aril-octahi- dro-1h-2-pirindinas 2-sustituidas.
ES385627A2 (es) Procedimiento para la preparacion de derivados de morfoli- na.
ES472511A1 (es) Procedimiento para la obtencion de derivados del acido 13 tianoprostanico
ES445592A1 (es) Procedimiento para la obtencion de derivados del acido pros-tanico.
ES398142A1 (es) Procedimiento para la preparacion de nuevos 1-feniltriaze- nos disustituidos en posicion 3.
ES436218A1 (es) Procedimiento para la obtencion de derivados de fenoxialca- nol.
ES455023A1 (es) Procedimiento para preparar derivados de tieno-(3, 2-c)-pi- ridina.
ES452391A1 (es) Procedimiento para la preparacion de nuevas arilalcohilami- nas sustituidas.
ES394894A1 (es) Procedimiento para la obtencion de acidos fenilacetohidro- xamicos.
ES401342A1 (es) Procedimiento para la preparacion de nuevos derivados de lapiridina y de sus sales.
ES406767A1 (es) Procedimiento para la preparacion de nuevos derivados de indol.
ES392356A1 (es) Un procedimiento para la preparacion de 17-aza-esteroides basicos y sus sales.
ES418271A1 (es) Procedimiento para la preparacion de nuevos 2-carboxi-4-oxo-4h, 10h-(2)-benzopirano-(4,3-g)-(1)-benzopiranos.
ES443610A1 (es) Procedimiento para preparar derivados de isoquinolina.
ES425405A1 (es) Procedimiento para preparar nuevos derivados del dibenzo (a,d) ciclohepteno.
ES301736A1 (es) Procedimiento para la preparaciën de nuevos derivados de tetrahidroisoquinolina
ES413745A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-betaf-fenilpropionico.
ES334932A1 (es) Procedimiento para preparar derivados de acidos hidrocinamicos alfa-sustituidos.